安信证券股份有限公司 关于嘉亨家化股份有限公司 2023 年半年度持续督导跟踪报告 | 保荐机构名称：安信证券股份有限公司 | 被保荐公司简称：嘉亨家化（300955） | | --- | --- | | 保荐代表人姓名：樊长江 | 联系电话：0755-81682816 | | 保荐代表人姓名：余中华 | 联系电话：0755-81682816 | 一、保荐工作概述 | 项 目 | 工作内容 | | --- | --- | | 1．公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不限 | | | 于防止关联方占用公司资源的制度、募集资金管理 | 是 | | 制度、内控制度、内部审计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3．募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 每月抄送对账单 | | （2）公司募集资金项目进展是否与信息披露文件一 | 是 | ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-033 嘉亨家化股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 根据深圳证券交易所《深圳证券交易所上市公司自律监管指引第 2 号—创业 板上市公司规范运作》及《深圳证券交易所创业板上市公司自律监管指南第 2 号—公告格式》的规定，将嘉亨家化股份有限公司（以下简称"公司"或"嘉亨家 化"）2023 年半年度募集资金存放与使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会证监许可[2021]488 号文批复，公司于 2021 年 3 月向社会公开发行人民币普通股（A 股）2,520.00 万股，每股发行价为 16.53 元， 应募集资金总额为人民币 41,655.60 万元，扣除不含税的发行费用人民币 4,351.08 万元后，实际募集资金净额为人民币 37,304.52 万元。该募集资金已于 2021 年 3 月到账。上述资金到账情况业经容诚会计师事务所（特殊普通合伙）"容诚验字 ...

Group 1: Investor Relations Activities - The company held an annual performance briefing on May 15, 2023, via an online platform [1] - Participants included the company's representatives and investors from various sectors [1] Group 2: Client Services - The company serves well-known brands such as Johnson & Johnson, Shanghai Jahwa, and Unilever [1] - The company is considering implementing an employee stock ownership plan and equity incentive programs in the future [2] Group 3: Stock Performance Concerns - The company's stock price has dropped from 60 to 20, a decline of approximately 67% [2] - The company attributes stock price fluctuations to macroeconomic factors and operational performance, stating there are no undisclosed major issues [2] Group 4: Employee Compensation and Retention - The company emphasizes a people-oriented approach, offering competitive salaries and benefits to retain talent [2] - Employee benefits include double weekends, annual leave, and year-end bonuses [2]

证券代码：300955 证券简称：嘉亨家化 嘉亨家化股份有限公司 投资者关系活动记录表 | --- | --- | |----------------|--------------------------------------| | 投资者关系活动 | 特定对象调研 | | 类别 | 媒体采访 | | | 新闻发布会 | | | 现场参观 | | | 其他 | | 参与单位名称及 | 中金公司 惠普、浙商基金 | | 人员姓名 | 建信信托 常馨月、丹羿投资 | | | 平基金 徐琳、宽合投资 | | | 安证券 杨柳、上海证券 | | | 安证券 徐熠雯 | | 时间 | 2023 年 5 月 8 日下午、 | | 地点 | 全资子公司湖州嘉亨实业有限公司会议室 | | 上市公司接待人 | | | 员姓名 | 代表傅冰红女士。 | | | | | | 技术研发中心和部分生产车间。 | | | 二、交流环节 | | | Q1 | | 投资者关系活动 | A | | 主要内容介绍 | | | | | | --- | |---------------------------------------------- ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-023 嘉亨家化股份有限公司 关于举办 2022 年度业绩说明会暨参加福建辖区 上市公司 2023 年投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 嘉亨家化股份有限公司（以下简称"公司"）已于 2023 年 4 月 24 日在巨潮资 讯网（www.cninfo.com.cn）披露了《2022 年年度报告》《2022 年年度报告摘要》。 为了更好地与广大投资者进行交流，使投资者能够进一步了解公司 2022 年 年度业绩、发展战略及经营状况，公司将于 2023 年 5 月 15 日（星期一）16：00- 17：30 举办 2022 年度业绩说明会暨参加由福建证监局、福建省上市公司协会与 深圳市全景网络有限公司联合举办的"2023 年福建辖区上市公司投资者网上集 体接待日活动"（以下简称"本次活动"）。 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP, 参与本次 ...

Financial Performance - The company reported a revenue of CNY 215,059,414.62 for Q1 2023, a decrease of 14.80% compared to CNY 252,430,407.65 in the same period last year[4] - Net profit attributable to shareholders was CNY 5,440,914.56, down 67.48% from CNY 16,732,432.89 year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 5,093,704.97, reflecting a decline of 68.71% compared to CNY 16,277,944.23 in the previous year[4] - Basic and diluted earnings per share decreased by 70.59%, from CNY 0.17 to CNY 0.05[4] - Total operating revenue for Q1 2023 was CNY 215,059,414.62, a decrease of 14.8% compared to CNY 252,430,407.65 in Q1 2022[24] - Total operating costs for Q1 2023 were CNY 212,451,631.74, down 9.3% from CNY 234,373,717.17 in the same period last year[25] - Net profit for Q1 2023 was CNY 5,440,914.56, a decline of 67.5% compared to CNY 16,732,432.89 in Q1 2022[25] - The total comprehensive income for the first quarter was CNY 5,417,378.91, a decrease from CNY 16,725,741.19 in the previous period, reflecting a decline of approximately 67.6%[26] - Basic and diluted earnings per share for the quarter were CNY 0.05, down from CNY 0.17 in the same period last year, representing a decrease of 70.6%[26] - The company reported a tax refund of CNY 44,489.59, a significant decrease from CNY 6,731,097.71 in the previous year[29] - The company’s other comprehensive income attributable to the parent company was CNY -23,535.65, compared to CNY -6,691.70 in the previous year, indicating a worsening of approximately 251.5%[26] Cash Flow and Assets - The company experienced a 24.59% increase in net cash flow from operating activities, amounting to CNY 17,991,142.68, compared to CNY 14,440,830.58 in the same period last year[4] - The company reported a significant increase in financing cash flow, with a net inflow of CNY 102,070,145.76, compared to a net outflow of CNY 5,928,124.54 in the previous year, marking an increase of 1821.79%[10] - The company reported a cash balance of RMB 138,428,435.85 as of March 31, 2023, compared to RMB 157,264,896.66 at the beginning of the year[20] - Cash inflow from operating activities totaled CNY 259,837,003.92, compared to CNY 312,140,370.72 in the previous year, indicating a decline of about 16.7%[29] - The net cash flow from operating activities was CNY 17,991,142.68, an increase from CNY 14,440,830.58 in the prior year, showing a growth of approximately 24.5%[29] - Cash outflow from investing activities was CNY 138,158,030.49, compared to CNY 68,505,128.76 in the previous year, reflecting an increase of about 102.5%[29] - Cash inflow from financing activities was CNY 160,800,000.00, significantly higher than CNY 32,000,000.00 in the previous year, marking an increase of 403.1%[29] - The net cash flow from financing activities was CNY 102,070,145.76, compared to a negative CNY 5,928,124.54 in the same period last year, indicating a turnaround[29] - The ending balance of cash and cash equivalents was CNY 138,428,435.85, down from CNY 142,276,797.24 in the previous year, a decrease of about 2.0%[29] Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,566,392,623.64, an increase of 1.69% from CNY 1,540,374,320.81 at the end of the previous year[4] - Current liabilities decreased to CNY 348,808,700.64 in Q1 2023, down 20.7% from CNY 439,638,624.76 in Q1 2022[22] - Long-term borrowings increased significantly to CNY 202,461,700.00 in Q1 2023, compared to CNY 90,266,700.00 in Q1 2022, reflecting a growth of 124.4%[22] - The company faced a 32.20% decrease in accounts payable, which fell to CNY 158,165,222.88 from CNY 233,272,115.51, due to payments made for construction projects[7] - The company's total assets increased to CNY 1,566,392,623.64 in Q1 2023, up from CNY 1,540,675,084.86 in Q1 2022[22] Research and Development - Research and development expenses increased by 47.88% to CNY 7,256,582.97, up from CNY 4,907,138.69 in the previous year[9] - Research and development expenses rose to CNY 7,256,582.97 in Q1 2023, an increase of 47.8% from CNY 4,907,138.69 in Q1 2022[25] Shareholder Information - The top shareholder, Shanghai Huiying Investment Partnership, holds 4,515,619 shares, representing 4.48% of the total shares[13] - The second-largest shareholder, Fujian Huixin Zhicheng Equity Investment Partnership, holds 2,575,435 shares, representing 2.55% of the total shares[13] - The company has not identified any other related party relationships among the top shareholders[14] - The company’s total restricted shares remain at 55,938,212, with no changes during the reporting period[16] Management and Future Plans - The company approved the conclusion of the "Technology R&D Center Upgrade Project" with surplus funds of RMB 13,527,500 to be permanently supplemented into working capital[17] - The company plans to invest an additional RMB 130,000,000 in the "Cosmetics and Plastic Packaging Container Production Base Construction Project" and extend the completion date to September 23, 2024[18] - The company’s independent directors have expressed clear agreement on the recent financial decisions made by the board[17] - The company’s independent sponsor, Anxin Securities, has issued a no-objection opinion on the recent financial decisions[17] - The company’s financial report indicates a focus on improving the efficiency of fund utilization in ongoing projects[17] - The company is expected to focus on market expansion and new product development in the upcoming quarters, although specific figures were not provided in the report[24]

嘉亨家化股份有限公司2022年年度报告全文 嘉亨家化股份有限公司 2022 年年度报告 2023-010 ...

Revenue and Profitability - Revenue for Q3 2022 was CNY 303,080,650.11, a decrease of 4.58% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 21,767,294.78, down 20.16% year-on-year[4] - Basic earnings per share for Q3 2022 was CNY 0.22, a decline of 20.02% compared to the previous year[4] - Total operating revenue for the current period is CNY 762,954,252.52, a decrease of 8.3% from CNY 831,891,115.67 in the previous period[21] - Net profit for the current period is CNY 48,295,502.28, a decline of 25.1% compared to CNY 64,457,198.73 in the previous period[22] - Earnings per share (EPS) for the current period is CNY 0.48, down from CNY 0.70 in the previous period[23] Assets and Liabilities - Total assets as of September 30, 2022, reached CNY 1,459,189,537.90, an increase of 7.46% from the end of the previous year[4] - The company’s total equity attributable to shareholders was CNY 967,195,684.68, reflecting a slight increase of 1.06% from the previous year[4] - The total liabilities increased to CNY 491,993,853.22 from CNY 400,796,781.00, indicating a rise in financial obligations[22] - Current assets decreased to CNY 655,538,075.55 from CNY 737,615,637.22 at the beginning of the year[19] - The company has ongoing investments in fixed assets totaling CNY 425,658,534.28[19] Cash Flow - Cash flow from operating activities for the first nine months was CNY 49,209,755.29, up 168.45% year-on-year[12] - The net cash flow from operating activities for Q3 2022 was ¥49,209,755.29, an increase from ¥18,331,066.93 in Q3 2021, reflecting improved operational efficiency[26] - Cash inflow from operating activities is CNY 847,858,178.85, slightly down from CNY 861,699,021.47 in the previous period[25] - The total cash outflow from investing activities was ¥189,627,200.50, compared to ¥482,150,310.07 in the previous year, indicating a significant reduction in investment expenditures[26] - The cash flow from financing activities included cash received from borrowings of ¥156,860,000.00, an increase from ¥87,900,000.00 in the previous year, reflecting increased leverage[26] Expenses and Costs - Total operating costs for the current period are CNY 709,499,338.40, down 6.0% from CNY 752,959,047.90 in the previous period[21] - Gross profit margin decreased to 6.9% from 9.5% year-on-year, reflecting increased cost pressures[22] - Research and development expenses for the current period are CNY 16,030,765.54, showing a slight decrease from CNY 16,330,753.95 in the previous period[22] - The company reported a tax expense of CNY 6,831,423.40, down from CNY 13,308,077.12 in the previous period, indicating improved tax efficiency[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 7,262[15] - The largest shareholder, Zeng Bensheng, holds 55.49% of shares, totaling 55,938,212 shares[15] - The company has a total of 4,515,619 shares held by Shanghai Huiying Investment Partnership, which is the largest among unrestricted shareholders[16]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥459.87 million, a decrease of 10.57% compared to ¥514.25 million in the same period last year[20]. - The net profit attributable to shareholders of the listed company was approximately ¥26.53 million, down 28.67% from ¥37.19 million in the previous year[20]. - The net cash flow from operating activities was approximately ¥25.89 million, representing a decline of 48.05% compared to ¥49.84 million in the same period last year[20]. - Basic earnings per share decreased by 38.10% to ¥0.26 from ¥0.42 in the previous year[20]. - Total assets at the end of the reporting period were approximately ¥1.34 billion, a decrease of 1.13% from ¥1.36 billion at the end of the previous year[20]. - The net assets attributable to shareholders of the listed company were approximately ¥945.32 million, down 1.23% from ¥957.07 million at the end of the previous year[20]. - The weighted average return on net assets was 2.73%, a decrease of 2.37% compared to 5.10% in the previous year[20]. - The company reported a total non-operating income of 1,331,783.79, after deducting the income tax impact of 315,460.23[25]. - The company reported a total of ¥31,060,795.66 in other receivables as of June 30, 2022, slightly down from ¥32,414,621.34[151]. - The company reported a net profit margin of approximately 5.9% for the first half of 2022, down from 7.5% in the same period of 2021[158]. Market and Industry Insights - The cosmetics market in China has shown significant growth, with retail sales increasing from 204.94 billion to 402.6 billion from 2015 to 2021, despite a 2.5% decline in the first half of 2022 due to external pressures[36]. - The company is positioned to benefit from the increasing demand for cosmetics production capacity, driven by both international brands localizing operations and the resurgence of domestic brands[37]. - The cosmetic industry is experiencing increased regulatory scrutiny, which is expected to raise industry standards and eliminate weaker competitors[40]. - The company faces risks including market demand fluctuations, high customer concentration, and raw material price volatility[3]. Research and Development - The company emphasizes continuous investment in R&D for product formulation and process optimization, aiming to enhance its market influence and customer base[34]. - The company is focusing on R&D in high-efficacy product formulations, including scalp care and skin barrier repair, to enhance product development efficiency[43]. - The company has added 9 new patents from January to July 2022, including 7 utility model patents and 2 invention patents[43]. - The company's R&D investment was ¥9,956,654.90, down 5.86% from ¥10,576,850.17 in the previous year[52]. Operational Strategies - The company has established long-term stable relationships with suppliers to ensure a steady supply of raw materials, which helps control procurement costs and reduce operational risks[29]. - The company operates under an OEM model for daily chemical products, with a focus on customer-specific production plans and quality control[30]. - The company is enhancing its quality control systems and production efficiency through lean management practices[42]. - The company aims to optimize its supply chain and production scheduling to reduce inventory levels and associated risks as it expands its operational scale[93]. Financial Management and Investments - The total investment during the reporting period was CNY 102,127,407.14, a significant decrease of 61.08% compared to CNY 262,374,785.38 in the same period last year[65]. - The company has ongoing projects with a total investment of CNY 65,287,818.54, with actual investment reaching CNY 306,697,818.45[68]. - The company has invested 6.6 million CNY in entrusted financial management products, with no overdue amounts reported[82]. - The company has identified risks related to the feasibility of its fundraising investment projects, which may not meet expected returns if market conditions change unfavorably[94]. Shareholder and Corporate Governance - The company’s total share capital is 100.8 million shares, with 55.49% held by foreign investors after the release of 19.66 million shares from lock-up[131][132]. - The company’s controlling shareholders and actual controllers maintained good integrity, with no significant debts due that were unpaid[111]. - The company did not engage in any asset or equity acquisitions or sales during the reporting period, nor did it have any related party transactions[112][113]. - The company has not reported any major changes in the feasibility of its investment projects[75]. Social Responsibility and Compliance - The company actively fulfilled its corporate social responsibilities, with a public donation expenditure of approximately CNY 260,000 for public welfare in the first half of 2022[103]. - The company maintained a strong focus on environmental protection, achieving ISO 14001 certification and ensuring that pollutant discharge met standards, with no environmental pollution incidents reported during the reporting period[103]. - The company has established a pandemic prevention working group and donated epidemic prevention materials as part of its social responsibility efforts[103]. - The company reported no major safety incidents during the reporting period, adhering to safety production guidelines and conducting regular safety training and assessments[103].